Who owns Stevanato Group S.p.A. (STVN)? Elite investor 13F holders
2 tracked elite investors reported holding Stevanato Group S.p.A as of 2026-06-30, including First Eagle Investment Management, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| First Eagle Investment Management | STEVANATO GROUP S P A | SHARE | 2026-06-30 | 2026-08-05 00:00:00 | 11045938.00 USD | 611286.000000 | Shares | add | Original filing |
| D.E. Shaw | STEVANATO GROUP S P A | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3660910.00 USD | 202596.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.